Company: PTPI
Filing Date: 2025-02-14
Form Type: S-1/A
Source: 0001410578-25-000137
Chunk: 294

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-02-14
Form: S-1/A
Chunk 294
---
 Waiver and Amendment, dated March 21, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on March 22, 2024).                                                                |
| 10.16  | ​ | Form of Amendment Agreement, dated October 11, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on October 17, 2024).                                                                                  |
| 10.17† | ​ | Offer Letter Amendment, effective as of October 16, 2024, by and between the Company and Fady Boctor (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on October 18, 2024).                                                                                                 |
| 10.18  | ​ | Form of Amendment Agreement, dated November 13, 2024, by and between Petros Pharmaceuticals, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.1 to the Company’s Quarterly Report on Form 10-Q filed with the SEC on November 13, 2024).                                                                |

| 10.20* | ​ | Form of Securities Purchase Agreement. |

II-6

| 16.1  
 21.1  |   | Letter dated January 12, 2024, from EisnerAmper LLP to the U.S. Securities and Exchange Commission (incorporated by reference to Exhibit 16.1 to the Company’s Current Report on Form 8-K filed on January 12, 2024). 
 List of Subsidiaries (incorporated by reference to Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed on March 31, 2022).                                                                                 |
|:------|:--|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 23.1* |   | Consent of Independent Registered Public Accounting Firm, Marcum LLP.                                                                                                                                                 |
| 23.2* |   | Consent of Independent Registered Public Accounting Firm, EisnerAmper LLP.                                                                                                                                            |
| 23.3* | ​ | Consent of Haynes and Boone, LLP (included in Exhibit 5.1)